1 01/12/2024 30/11/2025 2025-11-30 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2024-12-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 11657479 2024-12-01 2025-11-30 11657479 2025-11-30 11657479 2024-11-30 11657479 2023-12-01 2024-11-30 11657479 2024-11-30 11657479 2023-11-30 11657479 bus:RegisteredOffice 2024-12-01 2025-11-30 11657479 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 11657479 bus:Director1 2024-12-01 2025-11-30 11657479 core:WithinOneYear 2025-11-30 11657479 core:WithinOneYear 2024-11-30 11657479 bus:Micro-entities 2024-12-01 2025-11-30 11657479 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 11657479 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 11657479 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 11657479 bus:FullAccounts 2024-12-01 2025-11-30
Company registration number: 11657479
Cardimar Life Sciences BD Consultancy Ltd
Unaudited filleted financial statements
30 November 2025
Cardimar Life Sciences BD Consultancy Ltd
Contents
Directors and other information
Accountant's report
Statement of financial position and notes to the financial statements
Cardimar Life Sciences BD Consultancy Ltd
Directors and other information
Directors Miss Eva Simone Jordan
Company number 11657479
Registered office 749A Ormskirk Road
Wigan
WN5 8AT
Business address 749a Ormskirk Road
Wigan
WN5 8AT
Accountant Practical Business Solutions (NW) Limited
749A Ormskirk Road
Pemberton
Wigan
WN5 8AT
Cardimar Life Sciences BD Consultancy Ltd
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Cardimar Life Sciences BD Consultancy Ltd
Year ended 30 November 2025
In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the financial statements of Cardimar Life Sciences BD Consultancy Ltd for the year ended 30 November 2025 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given me.
As a practising member of the Chartered Institute of Management Accountants , I am subject to its ethical and other professional requirements which are detailed at www.cimaglobal.com.
This report is made solely to the board of directors of Cardimar Life Sciences BD Consultancy Ltd, as a body, in accordance with the terms of my engagement letter. My work has been undertaken solely to prepare for your approval the financial statements of Cardimar Life Sciences BD Consultancy Ltd and state those matters that we have agreed to state to the board of directors of Cardimar Life Sciences BD Consultancy Ltd as a body, in this report in accordance with the requirements of the Chartered Institute of Management Accountants as detailed at www.cimaglobal.com. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than Cardimar Life Sciences BD Consultancy Ltd and its board of directors as a body for my work or for this report.
It is your duty to ensure that Cardimar Life Sciences BD Consultancy Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Cardimar Life Sciences BD Consultancy Ltd. You consider that Cardimar Life Sciences BD Consultancy Ltd is exempt from the statutory audit requirement for the year.
I have not been instructed to carry out an audit or a review of the financial statements of Cardimar Life Sciences BD Consultancy Ltd. For this reason, I have not verified the accuracy or completeness of the accounting records or information and explanations you have given to me and I do not, therefore, express any opinion on the statutory financial statements.
Practical Business Solutions (NW) Limited
Chartered Global Management Accountants
749A Ormskirk Road
Pemberton
Wigan
WN5 8AT
17 August 2026
Cardimar Life Sciences BD Consultancy Ltd
Statement of financial position
30 November 2025
2025 2024
£ £
Fixed assets 1,846 1,034
_______ _______
Current assets 12,842 13,116
Creditors: amounts falling due within one year ( 12,609) ( 5,162)
_______ _______
Net current assets 233 7,954
_______ _______
Total assets less current liabilities 2,079 8,988
Provisions for liabilities ( 350) ( 196)
Accruals and deferred income ( 1,174) ( 720)
_______ _______
Net assets 555 8,072
_______ _______
Capital and reserves 555 8,072
_______ _______
Cardimar Life Sciences BD Consultancy Ltd
Year ended 30 November 2025
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 17 August 2026 , and are signed on behalf of the board by:
Miss Eva Simone Jordan
Director
Company registration number: 11657479
The company is a private company limited by shares, registered in United Kingdom.